Healthcare Stocks Are Down and Out. Opportunities Abound. A really good WSJ analysis. The link is a gift link for those of you who do not subscribe.
Predatory Journals: What Can We Do to Protect Their Prey? “The number of predatory journals is difficult to accurately determine but was estimated at more than 15 000 in 2021…
The practices that these entities employ include aggressive solicitation of manuscript submissions; the promise of extremely rapid turnaround times; and a lack of transparency about article submission, processing, and even withdrawal charges. Predatory journals may claim that they follow legitimate editorial and publishing practices but do not actually conduct peer review or such functions as archiving journal content, managing potential conflicts of interest, enabling corrections, and responding to author queries in a timely manner. In egregious cases, the ‘published’ articles never appear despite authors having paid the requested fees.”
About health insurance/insurers
NeueHealth to go private in $1.3B acquisition by New Enterprise Associates “NeueHealth, the care management company formerly known as Bright Health, is set to be acquired by venture capital partner New Enterprise Associates later this month.
NEA will purchase the company for $1.3 billion. NeueHealth shareholders will receive $7.33 per share in cash. NEA and 12 NeueHealth investors will exchange their stock for equity.”
Aetna sues drugmakers for widespread price-fixing and collusion “Aetna is taking legal action against Pfizer, Novartis, Teva Pharmaceuticals and others, saying the list of drugmakers conspired to overcharge the insurer, consumers and the federal government for generic drugs.”
10 largest Medicaid managed care plans FYI
About hospitals and healthcare systems
100 of the largest US hospitals and health systems | 2024 FYI
About the public’s health
Caution Needed in Interpreting the Evidence Base on Fluoride and IQ An excellent critique of the article in the same issue of JAMA evaluating levels of fluoride and potential harmful effects.
About healthcare IT
Top EHRs for 40 medical specialties FYI
About healthcare technology
FDA issues draft guidance on ensuring pulse oximeter accuracy across skin tones “To address those concerns, the FDA’s guidance instructs manufacturers on how to improve clinical trial designs and validation efforts for pulse oximeters designed for hospitals and doctors' offices—namely by increasing the number of representative participants in studies—as well as using both subjective and objective measures of skin tones in lab experiments and real-world data.”